Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Wall Street analysts’ average price target implies 117% upside for Vor Biopharma (VOR), pointing to significant bullish expectation divergence. The article also notes improving earnings estimate revisions, which could support additional stock upside. The piece is largely analytical and may influence sentiment more than fundamentals in the near term.

Analysis

Wall Street analysts’ average price target implies 117% upside for Vor Biopharma (VOR), pointing to significant bullish expectation divergence. The article also notes improving earnings estimate revisions, which could support additional stock upside. The piece is largely analytical and may influence sentiment more than fundamentals in the near term.